# PK Evaluation of a Nanoformed Oral IR Piroxicam Tablet in Healthy Subjects

> **NCT05104931** · PHASE1 · COMPLETED · sponsor: **Nanoform Finland Plc** · enrollment: 12 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Nanoformed Piroxicam IR Tablet
- **DRUG:** Felden (piroxicam) Tablets
- **DRUG:** Brexidol (piroxicam) Tablets

## Key facts

- **NCT ID:** NCT05104931
- **Lead sponsor:** Nanoform Finland Plc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-02
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05104931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05104931, "PK Evaluation of a Nanoformed Oral IR Piroxicam Tablet in Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05104931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*